HIGHLIGHTS
- What: This study provides a significant reference for the development of BD as a dietary supplement and pharmaceutical agent in the treatment of CAC. In the analysis, p and amp;lt; 0.05 was considered to be statistically significant.
- Who: Junliang Chen and colleagues from the Science and Research Center for Edible Fungi of Qingyuan County, Qingyuan, China have published the research work: Bondarzewia dickinsii Against Colitis-Associated Cancer Through the Suppression of the PI3K/AKT/COX-2 Pathway and Inhibition of PGE2 Production in Mice, in the Journal: Nutrients 2024, 4048 of 30/Oct . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.